Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

PRP may help improve ovarian function, but more research is needed for consistent results.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Norethindrone and levonorgestrel can enhance or inhibit root growth in Arabidopsis thaliana depending on the concentration.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Latanoprost helps pig hair follicles grow faster by keeping them in the growth phase longer.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Low prolactin in young women may increase heart and metabolism risks.

Testosterone reduces key molecules needed for early pregnancy in rats.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Neurosteroids help protect fetal brains from asphyxia damage.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

New compounds may help treat prostate issues without affecting androgen receptors.

Human placenta extract may promote hair growth by affecting certain lipid compounds.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

A new method to make Finasteride is more cost-effective and yields 16%.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.